Literature DB >> 10870981

Stability of human serum albumin during bioprocessing: denaturation and aggregation during processing of albumin paste.

J J Lin1, J D Meyer, J F Carpenter, M C Manning.   

Abstract

PURPOSE: To assess the impact of various bioprocessing steps on the stability of freshly precipitated human serum albumin (HSA) obtained from pooled human plasma.
METHODS: After initial precipitation of HSA from plasma, the resultant paste is either (a) lyophilized or (b) washed with acetone and then air-dried in order to obtain a dry powder. The structure of HSA was examined using Fourier transform infrared (IR) spectroscopy. The extent of aggregation of redissolved HSA was measured using both dynamic light scattering and SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
RESULTS: Both lyophilization and air-drying perturb the secondary structural composition of HSA, as detected by infrared (IR) spectroscopy. Upon dissolution of dried paste, most of the protein refolds to a native-like conformation. However, a small fraction of the protein molecules form soluble aggregates that can be detected by both dynamic light scattering and SDS-PAGE. The level of aggregation is so low that it could not be detected in the bulk by either circular dichroism or IR spectroscopy. The lyophilized protein, which appears to be more unfolded in the solid state than the acetone washed/air-dried material, exhibits a higher level of aggregation upon dissolution.
CONCLUSIONS: There is a direct correlation between the extent of unfolding in the solid state and the amount of soluble aggregate present after dissolution. Moreover, the presence of the aggregates persists throughout the remainder of the purification process, which includes dissolution, chromatography, sterile filtration and viral inactivation steps. Analytical methods used to monitor the stability of biopharmaceuticals in the final product can be used to assess damage inflicted during processing of protein pharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10870981     DOI: 10.1023/a:1007564601210

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Inhibition of stress-induced aggregation of protein therapeutics.

Authors:  J F Carpenter; B S Kendrick; B S Chang; M C Manning; T W Randolph
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Preparation and properties of serum and plasma proteins; a system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids.

Authors:  E J COHN; L E STRONG
Journal:  J Am Chem Soc       Date:  1946-03       Impact factor: 15.419

3.  Dehydration-induced conformational transitions in proteins and their inhibition by stabilizers.

Authors:  S J Prestrelski; N Tedeschi; T Arakawa; J F Carpenter
Journal:  Biophys J       Date:  1993-08       Impact factor: 4.033

4.  Quantitation of the area of overlap between second-derivative amide I infrared spectra to determine the structural similarity of a protein in different states.

Authors:  B S Kendrick; A Dong; S D Allison; M C Manning; J F Carpenter
Journal:  J Pharm Sci       Date:  1996-02       Impact factor: 3.534

5.  Infrared spectroscopic studies of lyophilization- and temperature-induced protein aggregation.

Authors:  A Dong; S J Prestrelski; S D Allison; J F Carpenter
Journal:  J Pharm Sci       Date:  1995-04       Impact factor: 3.534

Review 6.  Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment.

Authors:  W K Surewicz; H H Mantsch; D Chapman
Journal:  Biochemistry       Date:  1993-01-19       Impact factor: 3.162

7.  Identification and removal of polymer- and aggregate-forming proteins in human plasma albumin preparations.

Authors:  L B Jensen; J Dam; B Teisner
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

8.  Thermal stability of low molecular weight urokinase during heat treatment. I. Effects of protein concentration, pH and ionic strength.

Authors:  W R Porter; H Staack; K Brandt; M C Manning
Journal:  Thromb Res       Date:  1993-08-15       Impact factor: 3.944

Review 9.  Infrared methods for study of hemoglobin reactions and structures.

Authors:  A Dong; W S Caughey
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

10.  Thermal stability of low molecular weight urokinase during heat treatment. II. Effect of polymeric additives.

Authors:  M Vrkljan; T M Foster; M E Powers; J Henkin; W R Porter; H Staack; J F Carpenter; M C Manning
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

  10 in total
  5 in total

1.  Modifications of therapeutic proteins: challenges and prospects.

Authors:  Nigel Jenkins
Journal:  Cytotechnology       Date:  2007-05-25       Impact factor: 2.058

Review 2.  Post-translational modifications of recombinant proteins: significance for biopharmaceuticals.

Authors:  Nigel Jenkins; Lisa Murphy; Ray Tyther
Journal:  Mol Biotechnol       Date:  2008-06       Impact factor: 2.695

3.  A new microdispersed albumin derivative potentially useful for radio-guided surgery of occult breast cancer lesions.

Authors:  Gabriele Caviglioli; Marco Chinol; Sara Baldassari; Lucia Garaboldi; Guendalina Zuccari; Andrea Petretto; Giuliana Drava; Chiara Sinico; Giovanni Paganelli
Journal:  Sci Rep       Date:  2019-04-04       Impact factor: 4.379

4.  Biohybrid Electrospun Membrane for the Filtration of Ketoprofen Drug from Water.

Authors:  Rossella Castagna; Stefano Donini; Paolo Colnago; Andrea Serafini; Emilio Parisini; Chiara Bertarelli
Journal:  ACS Omega       Date:  2019-08-06

5.  pH-Dependent Aggregation in Intrinsically Disordered Proteins Is Determined by Charge and Lipophilicity.

Authors:  Jaime Santos; Valentín Iglesias; Juan Santos-Suárez; Marco Mangiagalli; Stefania Brocca; Irantzu Pallarès; Salvador Ventura
Journal:  Cells       Date:  2020-01-08       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.